Search International and National Patent Collections

1. (WO2017157248) USE OF TRIACETYL-3-HYDROXYPHENYLADENOSINE IN PREPARING PHARMACEUTICALS FOR TREATMENT OF ATHEROSCLEROSIS

Pub. No.:    WO/2017/157248    International Application No.:    PCT/CN2017/076304
Publication Date: Fri Sep 22 01:59:59 CEST 2017 International Filing Date: Sat Mar 11 00:59:59 CET 2017
IPC: A61K 31/7076
A61P 9/10
A61P 29/00
Applicants: JIANGSU TASLY DIYI PHARMACEUTICAL CO., LTD.
江苏天士力帝益药业有限公司
INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES
中国医学科学院药物研究所
Inventors: ZHU, Haibo
朱海波
WANG, Jing
王晶
Title: USE OF TRIACETYL-3-HYDROXYPHENYLADENOSINE IN PREPARING PHARMACEUTICALS FOR TREATMENT OF ATHEROSCLEROSIS
Abstract:
Provided are uses of an adenosine derivative, shown in formula (I), in preparing pharmaceuticals for the prevention and/or treatment of hyperlipidemia-induced monocytosis, and for the prevention and/or treatment of atherosclerosis. The prevention and/or treatment of atherosclerosis refers to the prevention and/or treatment of atherosclerosis-induced inflammatory monocytosis.